LexDanaLexDanabeta
Inventor

Srikant Viswanadha

Inventor
Hyderabad, IN

Overview

36→
Patents
2013–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 36 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds22%
Y02ATechnologies for adaptation to climate change16%
C12NMicroorganisms or enzymes4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07CAcyclic or carbocyclic compounds1%
PatentTitleYear
11,066,4023,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases202111,065,236Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor202111,020,399Intermediates useful in the synthesis of compounds as modulators of protein kinases202110,851,107Dual selective P13 delta and gamma kinase inhibitors202010,786,504Method of treatment and compositions comprising a dual PI3K delta-gamma kinase inhibitor and a corticosteroid202010,668,051Modulators of calcium release-activated calcium channel202010,611,759Glutaminase inhibitors202010,590,1293,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases202010,538,501Kinase modulators202010,442,7832,3-disubstituted chromen-4-one compounds as modulators of protein kinases201910,413,532Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor201910,322,130Substituted chromenones as modulators of protein kinases201910,246,450Modulators of calcium release-activated calcium channel201910,220,035Compounds as modulators of protein kinases201910,174,034Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer201910,087,1823,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases201810,058,539Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor20189,944,631Modulators of calcium release-activated calcium channel20189,815,831'3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases'20179,790,224'Dual selective PI3 delta and gamma kinase inhibitors'20179,783,533'Glutaminase inhibitors'20179,775,841'Compounds as modulators of protein kinases'20179,777,018'Compounds as modulators of GPR-119'20179,758,474'Immunomodulator and anti-inflammatory compounds'20179,758,514'Modulators of calcium release-activated calcium channel'20179,737,521'Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor'20179,421,209'Kinase modulators'20169,181,214'Bicyclic compounds as modulators of GPR-119'20159,018,375'Substituted chromenes as kinase modulators'20158,993,612'Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer'20158,921,364'Modulators of calcium release-activated calcium channel'20148,912,331'3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases'20148,686,048'Immunomodulator and anti-inflammatory compounds'20148,642,607'4H-chromen-4-one compounds as modulators of protein kinases'20148,481,739'3,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinases'20138,377,970'Modulators of calcium release-activated calcium channel'2013

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2013–2021Patents assigned to RHIZEN PHARMACEUTICALS SA (36)· patent assignee history
2013–2019Patents assigned to VAKKALANKA SWAROOP KUMAR V S (8)· patent assignee history
2013–2019Patents assigned to VISWANADHA SRIKANT (8)· patent assignee history
2013–2019Patents assigned to MUTHUPPALANIAPPAN MEYYAPPAN (7)· patent assignee history
2013–2020Patents assigned to INCOZEN THERAPEUTICS PVT LTD (5)· patent assignee history
2013–2021Based in Hyderabad, IN· patent location history
2018–2021Based in La Chaux-de-Fonds, CH· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
RHIZEN PHARMACEUTICALS SA362013–2021
VAKKALANKA SWAROOP KUMAR V S82013–2019
VISWANADHA SRIKANTself82013–2019
MUTHUPPALANIAPPAN MEYYAPPAN72013–2019
INCOZEN THERAPEUTICS PVT LTD52013–2020
Locations
LocationPatentsSpan
Hyderabad, IN342013–2021
La Chaux-de-Fonds, CH22018–2021